Response Pharmaceuticals
Response Pharmaceuticals is a startup headquartered in Falls Church, United States, founded in 2021. It has raised at least $3.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Response Pharmaceuticals has raised at least $3.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Response Pharmaceuticals sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Related
- Innovation profile of Falls Church
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Response Pharmaceuticals do?
Response Pharmaceuticals is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Response Pharmaceuticals raised?
At least $3.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Response Pharmaceuticals based?
Response Pharmaceuticals is headquartered in Falls Church, United States.
When was Response Pharmaceuticals founded?
Response Pharmaceuticals was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.